Model evaluation of target product profiles of an infant vaccine against respiratory syncytial virus (RSV) in a developed country setting

• Main Authors: Timothy Kinyanjui, Wirichada Pan-Ngum, Sompob Saralamba, Sylvia Taylor, Lisa White, D. James Nokes
• Other Authors: GlaxoSmithKline Pharmaceuticals SA/NV
• Format: Article
• Published: 2020
• Subjects: Biochemistry, Genetics and Molecular Biology; Immunology and Microbiology; Medicine; Veterinary
• Online Access: https://repository.li.mahidol.ac.th/handle/123456789/53561
• Institution: Mahidol University

© 2020 The Author(s) Respiratory syncytial virus (RSV) is a major cause of lower respiratory tract disease in children worldwide and is a significant cause of hospital admissions in young children in England. No RSV vaccine has been licensed but a number are under development. In this work, we prese...